Literature DB >> 3654970

Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.

M H Mogard1, V Maxwell, B Sytnik, J H Walsh.   

Abstract

The present study was designed to evaluate neurotensin as a hormonal regulator of gastric acid secretion in man. After a fat-rich meal, the strongest known stimulus of neurotensin release, plasma neurotensin-like immunoreactivity (NTLI) was elevated from 7.6 +/- 1.9 to 15.5 +/- 2.5 pM. Plasma NTLI was measured with antiserum L170, which requires the biologically active carboxyl-terminal hexapeptide of the neurotensin molecule for recognition and does not crossreact significantly with any known natural catabolite in human plasma. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 resulted in a plasma level of 14.7 +/- 2.1 pM, similar to the maximal physiological level observed after the fat-rich meal. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 during 2 h, however, failed to significantly inhibit peptone meal-stimulated gastric acid secretion measured by intragastric titration. The 2-h acid output to peptone was 40.8 +/- 6.2 and 41.3 +/- 6.9 mmol during the vehicle and the neurotensin infusion, respectively. Intravenous infusion of neurotensin at 100 or 400 pmol X kg-1 h-1 did not affect acid output, whereas at 1,600 pmol X kg-1 h-1, which resulted in a plasma neurotensin concentration of 725 +/- 80 pM, significantly reduced peptone meal-stimulated gastric acid secretion. The neurotensin-induced inhibition of acid output was independent of the hormone gastrin. The present results provide evidence against a hormonal role for neurotensin in the regulation of meal-stimulated gastric acid secretion in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654970      PMCID: PMC442347          DOI: 10.1172/JCI113161

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion.

Authors:  E Theodorsson-Norheim; S Rosell
Journal:  Regul Pept       Date:  1983-07

2.  Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin.

Authors:  A Rökaeus
Journal:  Acta Physiol Scand Suppl       Date:  1981

3.  Occurrence of neurotensin-immunoreactive cells in the digestive tract of lower vertebrates and deuterostomian invertebrates. A correlated immunohistochemical and radioimmunochemical study.

Authors:  M Reinecke; R E Carraway; S Falkmer; G E Feurle; W G Forssmann
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

4.  A radioimmunoassay for neurotensin in human plasma.

Authors:  A Shulkes; P Chick; H Wong; J H Walsh
Journal:  Clin Chim Acta       Date:  1982-10-13       Impact factor: 3.786

5.  Neurotensin inhibits meal-stimulated gastric acid secretion in man.

Authors:  P Skov Olsen; J Holst Pedersen; P Kirkegaard; F Stadil; J Fahrenkrug; J Christiansen
Journal:  Scand J Gastroenterol       Date:  1983-11       Impact factor: 2.423

6.  Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy.

Authors:  P S Olsen; J H Pedersen; P Kirkegaard; H Been; F Stadil; J Fahrenkrug; J Christiansen
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

7.  The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.

Authors:  Y C Lee; J M Allen; L O Uttenthal; M C Walker; J Shemilt; S S Gill; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

8.  Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: apparent conservation of the COOH-terminal region during evolution.

Authors:  R Carraway; S E Ruane; H R Kim
Journal:  Peptides       Date:  1982 Mar-Apr       Impact factor: 3.750

9.  Role of endogenous secretin in acid-induced inhibition of human gastric function.

Authors:  J H Kleibeuker; V E Eysselein; V E Maxwell; J H Walsh
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

10.  Pharmacological studies of neurotensin, several fragments and analogous in the isolated perfused rat heart.

Authors:  R Quirion; F Rioux; D Regoli; S St-Pierre
Journal:  Eur J Pharmacol       Date:  1980-09-05       Impact factor: 4.432

View more
  6 in total

1.  Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog.

Authors:  T Hashimoto; F Lluis; G Gomez; F L Hill; G H Greeley; J C Thompson
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Inhibitory effect of neurotensin on gastric acid secretion in rats. Development of a bioassay model.

Authors:  R A Hammer; R E Hernandez; A Shepard
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

3.  Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

Authors:  A Wettergren; B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

4.  Induction of the fed pattern of human exocrine pancreatic secretion by nutrients: role of cholecystokinin and neurotensin.

Authors:  M Katschinski; C Dippel; M Reinshagen; J Schirra; R Arnold; R Nustede; C Beglinger; G Adler
Journal:  Clin Investig       Date:  1992-10

5.  Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.

Authors:  P Layer; J J Holst; D Grandt; H Goebell
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

6.  Plasma Proneurotensin and Prediction of Cause-Specific Mortality in a Middle-aged Cohort During Long-term Follow-up.

Authors:  Ayesha Fawad; Andreas Bergmann; Janin Schulte; Zahra A Butt; Peter M Nilsson; Louise Bennet; Marju Orho-Melander; Olle Melander
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.